Potential issues associated with insurance coverage and ways to navigate these challenges are discussed by medical experts.
HERIZON-GEA-01 Results Indicate Potential 1L Use of Zanidatamab for Gastroesophageal Adenocarcinoma
The trial is investigating zanidatamab with/without tislelizumab plus chemotherapy in HER2-positive advanced or metastatic gastroesophageal adenocarcinoma.
Read More
Switching From MA to TM Increases Mental Health Care Use: Angela Liu, PhD, MPH
Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.
Listen
GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin
These results were presented during the press briefing ahead of the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium.
Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care
Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.
‘Our Responsibility Should Be to Give You the Closest Thing to a Normal Life’
Top 5 Most-Read NSCLC Articles of 2025
Top articles in non–small cell lung cancer (NSCLC) include FDA approvals, improved outcomes due to certain treatments, and updated data presented at conferences.